TORONTO and BOSTON - September 22, 2025 - TheNewswire — Sernova Biotherapeutics (“Sernova”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the appointment of John L. Brooks III as Chair of the Company’s Board of Directors.  “We are honored to have John lead our Board at this exciting time for Sernova,” said Jonathan Rigby, CEO of Sernova. “His deep expe ...

SALT LAKE CITY and BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the U.S. to support global ...

Biotech stocks can offer significant upside because they have high-growth potential if their drug candidates succeed in trials or gain FDA approval. For long-term biotech investors who can accept the risk of clinical-stage drugmakers, Eledon (ELDN) and Acumen (ABOS) are exciting opportunities to look at. However, given that they are penny stocks, they might be suitable for investors with a high-risk appetite. Eledon Pharmaceuticals (ELDN) Eledon Pharmaceuticals is a clinical-stage biotech company focused ...

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying... ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains CAMBRIDGE, MA / ACCESS Newswire / September 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of mNEXSPIKE® (COVID- 19 Vaccine, mRN ...

Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transplant for the treatment of hematological malignancies Company continues to engage in discussions aimed at obtaining capital and other resources to advance the SER-155 Phase 2 study and is preparing to rapidly operationalize the study, pending securing capital, with interim clinical results anticipate ...

Key Takeaways The Street bailed on HALO in the spring, right before a summer rally on big growth2026 profit projections, among five analysts, jumped 17.7% from $6.43 to $7.57HALO shares still trade under 11 times next year's EPS consensusHalozyme Therapeutics ((HALO) is a $9 billion biotech focused on oncology and boasting sales and profit growth of 29% and 46%, respectively, while trading a sub-11x forward P/E.HALO is focused on the development and commercialization of novel treatments for oncology indicat ...

平台功能特点 - 采用自研平台及MT4 MT5软件 支持网页端 电脑端 移动端 但不支持MacOS系统 [1] - 平台具有可定制性 但网页交易平台界面过时 部分功能难找 缺少两步登录和价格提醒功能 [1] 用户评价表现 - 交易执行速度快 界面简洁清晰 交易流程明了 [1] - 提供丰富教育资源和社区活动 有助于提升交易技能 [1] 美股市场表现(2025年9月22日) - 标准普尔500指数上涨0.44%至6693.75点 创历史新高 [1] - 道琼斯指数上涨0.14%至46381.54点 [1] - 纳斯达克100指数上涨0.55%至22788.98点 [1] - 罗素2000指数上涨0.60%至2463.34点 [1] - 科技股和小盘股走强带动涨势 强劲盈利和人工智能乐观发展支撑积极情绪 [1] 波动性与收益率 - VIX波动率指数下降约0.00%至15.70美元 [2] - 美国10年期收益率上升约4.14%至4.15% [2] 大宗商品表现 - WTI原油上涨0.42%至62.66美元/桶 [2] - 黄金期货上涨1.00%至3743.40美元/盎司 [2] 欧洲市场表现 - 富时100指数上涨0.11%至9226.68点 [2] - 德国DAX指数下跌0.48%至23527.05点 [2][3] - 法国CAC40指数下跌0.30%至7830.11点 [2] - 欧洲斯托克50指数下跌0.30%至5442.05点 [3] - 英国持谨慎乐观态度 欧洲大陆因增长担忧和政策不确定性普遍疲软 [3] 个股表现突出者 - INOVIO上涨8.30% 受强劲金价和对矿业产出乐观情绪支撑 [3] - BARRICKGOLD上涨7.43% 受投资者热情和情绪改善提振 [3] - NEKTAR上涨7.05% 重新燃起的购买兴趣和势头提振股价 [3] 今日市场动向(2025年9月23日) - 美国期货小幅下跌 市场关注美联储讲话和PCE通胀数据 [3] - 亚洲市场涨跌互现 中国蓝筹股走弱 香港恒生指数和上证综合指数双双下跌 [4] - 日本市场因假期休市 [4] 大宗商品最新动态 - 油价再次下滑 伊拉克与库尔德地区政府达成协议重新开放主要管道(23万桶/天)加剧供应担忧 [5] - 黄金创下新高 市场押注美联储将发出降息信号 交易员关注鲍威尔讲话和美国通胀数据 [6] 实时市场情绪(欧盟开放时段) - 风险偏好呈现轻度风险偏好状态 [7] - VIX指数在谨慎乐观中走高但保持稳定 [7] - 美元指数因美元走弱支撑金属 持有或小幅下跌 [7] - 黄金处于或接近历史高位 上涨0.2-0.3% [7] - WTI原油受伊拉克管道重新开放供应压力而下跌 [7] - 比特币美元汇率表现好坏参半/持平 加密货币市场等待更明确宏观信号 [7]

With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:Wall Street expects AutoZone Inc. AZO to report quarterly earnings at $50.83 per share on revenue of $6.24 million before the opening bell, according to data from Benzinga Pro. AutoZone shares slipped 0.5% to close at $4,121.00 on Monday.Firefly Aerospace Inc. FLY posted a second-quarter loss of $5.78 per share, versus a year-ago loss of $4.60 per share. Its sales decl ...

Pfizer's plan to enter the booming obesity market took an expensive new turn.Shares of a little-known biotechnology stock called Metsera (MTSR 60.80%) popped on Monday, Sept. 22, after Pfizer (PFE 0.04%) announced it would be acquiring it for a steep premium. Under the terms of the agreement, Pfizer will spend $47.50 per share, or about $4.9 billion up front.In addition to an up-front payment that is 43% above the previous trading day's closing price, Metsera shareholders will receive a contingent value rig ...